Correlation Between Emcure Pharmaceuticals and Cyber Media

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Emcure Pharmaceuticals and Cyber Media at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Emcure Pharmaceuticals and Cyber Media into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Emcure Pharmaceuticals and Cyber Media Research, you can compare the effects of market volatilities on Emcure Pharmaceuticals and Cyber Media and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Emcure Pharmaceuticals with a short position of Cyber Media. Check out your portfolio center. Please also check ongoing floating volatility patterns of Emcure Pharmaceuticals and Cyber Media.

Diversification Opportunities for Emcure Pharmaceuticals and Cyber Media

0.9
  Correlation Coefficient

Almost no diversification

The 3 months correlation between Emcure and Cyber is 0.9. Overlapping area represents the amount of risk that can be diversified away by holding Emcure Pharmaceuticals and Cyber Media Research in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyber Media Research and Emcure Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Emcure Pharmaceuticals are associated (or correlated) with Cyber Media. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyber Media Research has no effect on the direction of Emcure Pharmaceuticals i.e., Emcure Pharmaceuticals and Cyber Media go up and down completely randomly.

Pair Corralation between Emcure Pharmaceuticals and Cyber Media

Assuming the 90 days trading horizon Emcure Pharmaceuticals is expected to generate 0.76 times more return on investment than Cyber Media. However, Emcure Pharmaceuticals is 1.31 times less risky than Cyber Media. It trades about -0.19 of its potential returns per unit of risk. Cyber Media Research is currently generating about -0.24 per unit of risk. If you would invest  142,070  in Emcure Pharmaceuticals on December 24, 2024 and sell it today you would lose (39,235) from holding Emcure Pharmaceuticals or give up 27.62% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy100.0%
ValuesDaily Returns

Emcure Pharmaceuticals  vs.  Cyber Media Research

 Performance 
       Timeline  
Emcure Pharmaceuticals 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Emcure Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Cyber Media Research 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Cyber Media Research has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Emcure Pharmaceuticals and Cyber Media Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Emcure Pharmaceuticals and Cyber Media

The main advantage of trading using opposite Emcure Pharmaceuticals and Cyber Media positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Emcure Pharmaceuticals position performs unexpectedly, Cyber Media can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyber Media will offset losses from the drop in Cyber Media's long position.
The idea behind Emcure Pharmaceuticals and Cyber Media Research pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device